Back to Search Start Over

Hijacking a neurodevelopmental epigenomic program in metastatic dissemination of medulloblastoma

Authors :
Han Zou
Bradley Poore
Emily Brown
Jieqi Qian
Bin Xie
Evridiki Asimakidou
Vladislav Razskazovskiy
Deanna Ayrapetian
Vaibhav Sharma
Shunjin Xia
Fei Liu
Apeng Chen
Yongchang Guan
Zhengwei Li
Siyi Wanggou
Olivier Saulnier
Michelle Ly
Wendy Fellows-Mayle
Guifa Xi
Tadanori Tomita
Adam Resnick
Stephen Mack
Eric Raabe
Charles Eberhart
Dandan Sun
Beth Stronach
Sameer Agnihotri
Gary Kohanbash
Songjian Lu
Karl Herrup
Jeremy Rich
George K. Gittes
Alberto Broniscer
Zhongliang Hu
Xuejun Li
Ian Pollack
Robert Friedlander
Sarah Hainer
Michael Taylor
Baoli Hu
Publication Year :
2022
Publisher :
Research Square Platform LLC, 2022.

Abstract

How dysregulation of neurodevelopment relates to medulloblastoma (MB), the most common pediatric brain tumor, remains elusive. Here, we uncovered a neurodevelopmental epigenomic program being hijacked to induce MB metastatic dissemination. Unsupervised analyses by integrating publicly available datasets with our newly generated data revealed that SMARCD3/BAF60C regulates DAB1-mediated Reelin signaling in Purkinje cell migration and MB metastasis by orchestrating cis-regulatory elements (CREs) at the DAB1 locus. We further identified that a core set of transcription factors, enhancer of zeste homolog 2 (EZH2) and nuclear factor I X (NFIX), coordinates with the CREs at the SMARCD3 locus to form a chromatin hub for controlling SMARCD3 expression in the developing cerebellum and metastatic MB. Elevated SMARCD3 activates Reelin/DAB1-mediated Src kinase signaling, resulting in MB response to Src inhibition. These data deepen our understanding of how neurodevelopmental programming influences disease progression and provide a potential therapeutic option for MB patients.

Details

Database :
OpenAIRE
Accession number :
edsair.doi...........7b3a50a0591a255866b073c4112a4aad
Full Text :
https://doi.org/10.21203/rs.3.rs-1270726/v1